Between 2010 and 2011, 1900 men in a region in southern Sweden aged 65 years were invited to attend for VAScular and Chronic Obstructive Lung disease (VASCOL) baseline (Wave 1) assessments which included physiological measurements, blood sampling and a self-report survey of lifestyle and previous medical conditions.

2025年1月7日 · Vascol (Atorvastatin) is an HMG-CoA reductase inhibitor used to lower lipid levels and reduce the risk of cardiovascular disease including myocardial infarction and stroke.

2021年7月26日 · Participants: Between 2010 and 2011, 1900 men in a region in southern Sweden aged 65 years were invited to attend for VAScular and Chronic Obstructive Lung disease (VASCOL) baseline (Wave 1) assessments which included physiological measurements, blood sampling and a self-report survey of lifestyle and previous medical conditions. In 2019 ...

Compromiso de Calidad | VASCOL S.A.C.I. empresa paraguaya dedicada a la importación, representación y distribución de productos nacionales e internacionales de alta calidad.

2023年12月20日 · VASCOL was based on physiological measurements, but also completion of self-reported surveys–including information about multidimensional breathlessness and fatigue (through D-12, MDP and FACIT-F).

Indicaciones terapéuticas: VASCOL ® (Atorvastatina) está indicado en conjunto con modificaciones a la dieta en los siguientes casos: En pacientes con triglicéridos, apolipoproteína B (Apo-B), colesterol LDL (lipoproteína de baja densidad) y colesterol total elevados. En pacientes con niveles de colesterol HDL (lipoproteína de alta ...

Catálogo de productos Vascol, S.A., Paraguay, - página de empresa. Información de contacto, datos de empresa - dirección, teléfonos, fax. productos y servicios Allbiz

Indicaciones terapéuticas: VASCOL® (atorvastatina) está indicada en pacientes con hipercolesterolemia primaria, hiperlipidemia mixta e hipercolesterolemia familiar (heterocigótica u homocigótica).

VAScular and Chronic Obstructive Lung disease (VASCOL): a longitudinal study on morbidity, symptoms and quality of life among older men in Blekinge county, Sweden

(VASCOL) study is an epidemiological, longitudinal, cohort study to describe the relationship between vascular diseases and COPD. Since its beginning in 2010, the scope has broaden to also focus on QoL, self- reported measures of breathlessness and other symptoms of cardiovascular diseases. In this paper, we present the VASCOL study design,